Boston Scientific Corp. [NYSE: BSX] stock went on a downward path that fall over -0.92% on Monday, amounting to a one-week price increase of more than 6.59%. Over the last 12 months, BSX stock rose by 39.34%. The one-year Boston Scientific Corp. stock forecast points
Boston Scientific Corp. [NYSE: BSX] stock went on an upward path that rose over 1.02% on Monday, amounting to a one-week price increase of more than 0.86%. Over the last 12 months, BSX stock rose by 29.27%. The one-year Boston Scientific Corp. stock forecast points
Boston Scientific Corp. [NYSE: BSX] traded at a low on Monday, posting a -0.93 loss after which it closed the day’ session at $67.44. The results of the trading session contributed to over 6527032 shares changing hands. Over the past one week, the price volatility
Boston Scientific Corp. [NYSE: BSX] price plunged by -0.04 percent to reach at -$0.03. The company report on April 8, 2024 at 12:00 AM that Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE™ Nav Pulsed Field Ablation Catheter and FARAVIEW™ Software Module. Boston Scientific Corporation
Boston Scientific Corp. [NYSE: BSX] traded at a low on Tuesday, posting a -0.95 loss after which it closed the day’ session at $67.45. The company report on April 1, 2024 at 8:00 AM that Boston Scientific Announces Conference Call Discussing First Quarter 2024 Results.
Boston Scientific Corp. [NYSE: BSX] gained 1.00% on the last trading session, reaching $68.62 price per share at the time. The company report on March 25, 2024 at 9:30 PM that Scivita Medical Expands Collaboration with Boston Scientific. Recently, Scivita Medical Technology Co., Ltd. (“Scivita
Boston Scientific Corp. [NYSE: BSX] stock went on an upward path that rose over 0.82% on Tuesday, amounting to a one-week price increase of more than 0.44%. The company report on March 1, 2024 at 6:55 AM that Boston Scientific Receives FDA Approval for the
Boston Scientific Corp. [NYSE: BSX] loss -2.28% or -1.54 points to close at $66.12 with a heavy trading volume of 7994435 shares. The company report on March 1, 2024 at 6:55 AM that Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated Balloon. First coronary
Boston Scientific Corp. [NYSE: BSX] jumped around 0.3 points on Monday, while shares priced at $67.43 at the close of the session, up 0.45%. The company report on March 1, 2024 at 6:55 AM that Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated Balloon.
Boston Scientific Corp. [NYSE: BSX] jumped around 0.4 points on Tuesday, while shares priced at $66.22 at the close of the session, up 0.61%. The company report on February 14, 2024 at 8:15 AM that Boston Scientific: Meeting Disabilities With Inclusion. Boston Scientific Jackie MacDonald
© 2024, Powered by Smart TechOne
